SEC Tracker
Get the app

Enanta Pharmaceuticals ENTA

At the annual meeting of stockholders held on March 2, 2023

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Enanta Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.